News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nitec Pharma AG Raises $22 Million


9/30/2008 8:01:51 AM

Nitec Pharma AG, a Swiss drug company focused on chronic inflammation and pain-related diseases, has raised CHF 24 million (approx. $22m) in new VC funding. TVM Capital led the round, and was joined by Deutche Bank and return backers NGN Capital, Global Life Sciences Venture and Atlas Venture. www.nitecpharma.com



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES